MedPath

Darifenacin

These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004

Approved
Approval ID

7ae60119-e22c-4806-a5d8-db7c9e8984a2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 25, 2023

Manufacturers
FDA

Macleods Pharmaceuticals Limited

DUNS: 862128535

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Darifenacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code33342-277
Application NumberANDA207302
Product Classification
M
Marketing Category
C73584
G
Generic Name
Darifenacin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 25, 2023
FDA Product Classification

INGREDIENTS (10)

CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: L11K75P92J
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
DARIFENACIN HYDROBROMIDEActive
Quantity: 15 mg in 1 1
Code: CR02EYQ8GV
Classification: ACTIM
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT

Darifenacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code33342-276
Application NumberANDA207302
Product Classification
M
Marketing Category
C73584
G
Generic Name
Darifenacin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 25, 2023
FDA Product Classification

INGREDIENTS (8)

DARIFENACIN HYDROBROMIDEActive
Quantity: 7.5 mg in 1 1
Code: CR02EYQ8GV
Classification: ACTIM
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: L11K75P92J
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Darifenacin - FDA Drug Approval Details